Dividend Stocks Dividends Portfolio

Dividend Portfolio: 12/2/2022 Week in Review

Weekly update on a long-term dividend growth portfolio from a young investor to show you how I’m investing to reach financial independence! To date the portfolio is up 2.4% and is beating SPY by over 11%!

Welcome back to the weekly Dividend Dollars portfolio review! This portfolio update is brought to you by Sharesight, a portfolio tracking tool that I am happy to partner with. Their platform makes tracking trading and dividend history, understanding your performance, and saving time a breeze. I wrote a review of the product that you can read here if you’re interested in learning more! Click the link above or the picture below to get a special offer only for Dividend Dollar readers!

Here at Dividend Dollars, our investing approach is a dividend growth strategy with aspects of value investing and fundamental analysis. I am a young investor in my 20’s and by sticking to this strategy over the long term, the magical powers of compounding are on my side. This allows me to more easily build substantial positions in dividend paying stocks over time, which will one day help me reach the ultimate goal of being financially free through the sources of passive income they provide. You can read more about the strategy here. Let’s dive into the portfolio review!

Portfolio Value

To date, I have invested $12,340 into the account the total value of all positions plus any cash on hand is $12,639.84. That’s a total gain of 2.43%. The account is up $82.60 for the week which is a 0.66% gain.

We started building this portfolio on 9/24/2021 and when compared to the S&P 500 we are outperforming the market so far! Within that same timeframe, the S&P 500 is down -8.61% which puts us 11% higher than the market! I love tracking my portfolio against a benchmark like the S&P. The above chart comes from Sharesight which makes portfolio and dividend management a breeze!

We added $60 in cash to the account this week, trades made will be broken out below.


Above is a dashboard of the portfolio that tracks annual dividend income, yield, beta, dividend growth, and more.

Below is a table of everything we are invested in so far. There you can see my number of shares, shares bought through dividend reinvestments, average cost, gains, and more. The tickers in green are positions that I bought shares in this week, the blue ones are positions that I reinvested dividends into, the yellow ones are positions that announced a dividend increase this week, and the red are positions that I trimmed. Our moves this week decreased my PADI by $9 to $467.


This week I received a $9.52 dividend from Intel, a $3.51 dividend from $XYLG, and a $3.72 dividend from Cummins

In my portfolio, all positions have dividend reinvestment enabled. I don’t hold onto the dividend, I don’t try to time the reinvestment, I just let my broker do it automatically.

Dividends received for 2022: $349.91

Portfolio’s Lifetime Dividends: $372.83


This week was a week of playing with options (a bit too much) and reorganizing my Healthcare exposure. While holding onto cash and waiting for a drop to add, I’ve fallen victim to trying to boost my gains by day trading with it. Over the last month I lost roughly $230 to day trading options while holding onto my cash. I need to be better about this! Monday and Wednesday show some bad plays in that realm.

Monday was my typical automatic investments into my ETFs. Wednesday, I consolidated my short position into only $SDS and added to it. I planned on investing in $CCO long term and started a position but later questioned it and sold the next day.

Thursday, I sold $AMGN and $MRK for +40% gains and decided to start a position in $JNJ as my chosen healthcare stock. The reasoning for this is that I do not know much about Amgen’s or Merck’s products. I know they have good patents right now that are really performing well, but I don’t know how sustainable that is or how long those patents are good for. Will they be able to create a new cash generating products after their current patents expire? I don’t know and I’m not in the business of trying to guess that. I like $JNJ because they have a base business of well-known healthcare staples that supports the riskier pharmaceutical endeavors, which is much more comfortable for me as an investor.

Friday was only some dividend reinvestments.

Below is a breakdown of the trades I made this week and the reasoning behind them!

  • November 28th, 2022
    • Apple ($AAPL) – Entered 12/16 143P at 3.35 and exited at 3.90 ($55 gain)
    • Netflix ($NFLX) – Overnight 12/9 335C from last Friday entered at $0.49 and exited at $0.27 ($22 loss)
    • SPDR S&P 500 ETF ($SPY) – added $10 at $397.55 per share (weekly automatic buy) and dividend reinvested
    • Global X S&P 500 Covered Call & Growth ETF ($XYLG) – added $10 at $25.86 per share (weekly automatic buy)
    • Schwab US Dividend Equity ETF ($SCHD) – added $10 at $77.55 per share (weekly automatic buy)
  • November 30th, 2022
    • Clear Channel Outdoor ($CCO) – bought 100 shares at $1.06
    • NVIDIA ($NVDA) – entered 12/9 $150P at $2.22 and exited at $1.12 ($110 loss)
    • S&P 500 Bear 3X ($SPXS) – Sold 2 shares at $19.52 to add to the 2x position
    • ProShares Ultra Short S&P 500 ($SDS) – added 3 shares at $41.96
    • Global X S&P 500 CC & Growth ETF ($XYLG) – dividend reinvested
  • December 1st, 2022
    • Clear Channel Outdoor ($CCO) – sold 100 shares at $1.08 ($2.14 gain)
    • Amgen $AMGN) – sold whole position at $282.68 ($100.40 gain)
    • Merck ($MRK) – sold whole position at $109.81 ($62.08 gain)
    • Johnson & Johnson ($JNJ) – bought 1 share at $178.48
  • December 2nd, 2022
    • Intel ($INTC) – dividend reinvested
    • Cummins ($CMI) – dividend reinvested

Next week I will continue to add $10 into each ETF ($SPY, $XYLG, and $SCHD) and will continue to hold onto the rest of my cash. I really want to deploy this cash position into $T, $CMCSA, and $INTC to build 100 share positions in them for covered call activities.


That is it for the update this week. Let’s kill it next week. Stay patient and be ready to buy income producing assets at a discount!

Read the weekly market review to get a recap of the week and help arm yourself with market knowledge! This weekly update and the last weekly update provide opinion pieces from myself and explain why I am bearish on the market.

Let me know what you think of the progress so far, share with me your progress and questions, interact with me on twitter and Instagram using the links below!

Thank you for reading! See you next week and stay safe!


Dividend Dollars

Leave a Reply